Highlights
NASDAQ: MNLO       Menlo Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
6.68   +0.01 (0.15%)  6.54 - 7.48  135,100

Overview

 
Avg Volume (4 weeks):273,800
4 Weeks Range:3.99 - 7.48
4 Weeks Price Volatility (%):
77.08%
52 Weeks Range:2.69 - 9.031
52 Weeks Price Volatility (%):
62.92%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Menlo Therapeutics Inc is a US-based late-stage biopharmaceutical company which focuses on the development and commercialization of Serlopitant for the treatment of pruritus associated with dermatologic conditions such as atopic dermatitis, psoriasis, and prurigo nodularis. The pipeline product of the company includes Prurigo Nodularis, Prurigo Dermatitis, Psoriasis and Refractory Chronic Cough.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers